Evidence map›Paper›PMID 38250891›Full record

ArticleVaccines2024

The Development of a Rabies Virus-Vectored Vaccine against

Shantel Rios, Bibek Bhattachan, Kruthi Vavilikolanu, Chrysoula Kitsou, Utpal Pal, Matthias J Schnell

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Shantel RiosDepartment of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.ORCID 0009-0004-4809-0567
Bibek BhattachanDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20740, USA.
Kruthi VavilikolanuDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20740, USA.
Chrysoula KitsouDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20740, USA.
Utpal PalDepartment of Veterinary Medicine, University of Maryland, College Park, MD 20740, USA.
Matthias J SchnellDepartment of Microbiology and Immunology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
University of Maryland, College Park · USThomas Jefferson University · US

Funding

Multivalent Tick-Microbe targeted Lyme disease vaccinesR01AI154542 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI PAL, UTPAL, SCHNELL, MATTHIAS JOHANNES · 2020 to 2025
$3.5M
NIAID NIH HHS R01 AI154542
6 · The paper itself

Abstract

Lyme disease (LD) is the most common tick-borne illness in the United States (U.S.), Europe, and Asia.

Indexed as

Borrelia burgdorferiLyme disease vaccinerabies virusviral vaccine vector

Identifiers

PMID38250891
PMCPMC10820992
OpenAlexW4390831177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.